Delivery Order SPE2DB24D2216-SPE2DB25FGPBF
Award Date 6/24/25
Potential Completion Date 7/16/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $100,573.20 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 unit vials, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product used in medical applications, and this order supports the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XEOMIN 200 Unit Vials valued at $13,409.76 on May 30, 2025, with an ultimate completion date of June 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product used for therapeutic and cosmetic applications, and this procurement...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of XEOMIN 50 unit vials, with a ceiling value of $10,941.84 and a firm fixed price structure. This non-set-aside contract is scheduled for completion by September 30, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. XEOMIN is a botulinum toxin product used in medical and cosmetic applications, and this delivery...
- The Defense Logistics Agency (DLA) awarded a $27,937 delivery order to AmerisourceBergen Drug Corp for XEOMIN 200 Unit Vials, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order, issued on July 31, 2025, represents a competitive, non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product used for medical and aesthetic purposes, reflecting the breadth of pharmaceutical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of XEOMIN 100 UT vials valued at $9,498.58 under a firm fixed price contract type. The delivery order, which is expected to be completed by August 28, 2025, represents a non-competitive award with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product commonly used in medical and cosmetic...
- The Defense Logistics Agency awarded a $8,939.84 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin-based pharmaceutical used for therapeutic and cosmetic applications. This competitively awarded, firm fixed-price contract was issued on September 12, 2025, with an ultimate completion date of October 3, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $5,587.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of XEOMIN 200 Unit Vials, with performance to be completed by August 1, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product used in medical and therapeutic applications, and this delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for XEOMIN 100 Unit vials with a ceiling value of $8,381.10. This firm fixed price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XEOMIN 100 Unit Vials, with a ceiling value of $1,676.22. The order was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this delivery from its corporate office location. This delivery order...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of XEOMIN 100 unit vials. This competitive delivery order, valued at $46,375.42, represents a firm fixed-price contract with an ultimate completion date of September 15, 2025. The award was not set-aside and reflects AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements through open competition. The work will be...